Retinalgenix Technologies (QB) Quote - RTGN | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
USOTC
Retinalgenix Technologies Inc (QB) (RTGN) Share Price

Retinalgenix Technologies Inc (QB) (RTGN)

3.50

0.00

( 0.00% )

Updated: 00:19:33

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

3.50

Bid

1.60

Offer

5.25

Volume

-

0.00 Day's Range 0.00

3.10 52 Week Range 3.50

Market Cap

Previous Close

3.50

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

17,996,033

Dividend Yield

-

PE Ratio

-30.12

Earnings Per Share (EPS)

-0.12

Revenue

-

Net Profit

-2.09M

Retinalgenix Technologies Inc now including DNA?GPS is an R&D Ophthalmic and genetic mapping software development company based in Petaluma California. Its core is in EYECARE Imagining, patient home monitoring and in .pharmaco -mapping patient software App Retinalgenix Technologies Inc now including DNA?GPS is an R&D Ophthalmic and genetic mapping software development company based in Petaluma California. Its core is in EYECARE Imagining, patient home monitoring and in .pharmaco -mapping patient software App

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.retinalgenix.com.

Headquarters

Lewes, Delaware, USA

Founded

-

Retinalgenix Technologies Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker RTGN. The last closing price for Retinalgenix Technologies (QB) was US$3.50. Over the last year, Retinalgenix Technologies (QB) shares have traded in a share price range of US$ 3.10 to US$ 3.50.

Retinalgenix Technologies (QB) currently has 17,996,033 shares in issue. The market capitalisation of Retinalgenix Technologies (QB) is US$62.99 million. Retinalgenix Technologies (QB) has a price to earnings ratio (PE ratio) of -30.12.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form EFFECT - Notice of Effectiveness

Form EFFECT - Notice of Effectiveness

Form EFFECT - Notice of Effectiveness

Form EFFECT - Notice of Effectiveness

Form D - Notice of Exempt Offering of Securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	3.5	3.5	3.5	0	0	CS
26	0	0	3.5	3.5	3.5	0	0	CS
52	0.4	12.9032258065	3.1	3.5	3.1	71	3.42	CS
156	0.5	16.6666666667	3	20	3	137	6.7902133	CS
260	0.5	16.6666666667	3	20	3	137	6.7902133	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ISUNQiSun Inc (CE)	US$ 0.0007 (69,900.00%)	19.21k
TTCFQTattooed Chef Inc (CE)	US$ 0.0002 (19,900.00%)	47.31k
HENCHero Technologies Inc (CE)	US$ 0.0001 (9,900.00%)	200k
ECPNEl Capitan Precious Metals Inc (CE)	US$ 0.0001 (9,900.00%)	2.25k
YAYOYayYo Inc (CE)	US$ 0.0001 (9,900.00%)	2.83k
EGBBEarth Gen Biofuel Inc (CE)	US$ 0.000001 (-99.95%)	8k
CNVIFConavi Medical Corporation (PK)	US$ 0.0007 (-99.88%)	1.86k
SCNGSC Holdings Corporation (CE)	US$ 0.000001 (-99.50%)	55k
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.000001 (-99.50%)	2.4k
BDPTDBioadaptives Inc	0.081275 (-99.10%)	78.57k
GRLFGreen Leaf Innovations Inc (PK)	US$ 0.0001 (0.00%)	210.2M
THBDThird Bench Inc (PK)	US$ 0.0003 (200.00%)	112.61M
QEDNQED Connect Inc (PK)	US$ 0.0005 (25.00%)	78.09M
RDARRaadr Inc (PK)	US$ 0.0007 (16.67%)	70.16M
HCMCHealthier Choices Management Corporation (PK)	US$ 0.000001 (0.00%)	69.96M

diggitydoodle

diggitydoodle 35 seconds ago

FOXO dropping like a stone. RNVA treading water at worthless.
Geez.
RNVA!!$$?????????????

ddls

ddls 41 seconds ago

When exactly is this masterpiece taking off.? Maybe when the Mediterranean freezes over?😎

BIOCHEMUP

BIOCHEMUP 55 seconds ago

Why is in down 50% since $0.02?

Steady_T

Steady_T 1 minute ago

Actually AVXL started up before SAVA. But SAVA is up much more on a percentage basis now at 2:20 EST.

TheFirm

TheFirm 1 minute ago

Receiver just filed with court $76,000 in legal fees.... how is NSAV paying that? a token? they can just o sell one of those wonka tokens easily right?

Penny Grabber

Penny Grabber 1 minute ago

After the shareholder meeting volume has been elevated. The last round of funding was 550k shares or so plus 1.7M in warrants that can be exercised at 2.98

Since 1.7M was more than 19.99% of shares outstanding it needed approval. It got approval at that meeting.

Liquidi

runncoach

runncoach 1 minute ago

Quite the run on no news

janice shell

janice shell 2 minutes ago

Sounds as if he can't wait to leave...

Longstrongsilver

Longstrongsilver 2 minutes ago

That’s a fancy way of saying still down about 25% from recent highs. I’m sincerely hoping he comes through with all the hype , but a little tacky for any ceo/officer of a company to state expected share price (s). Keep increasing the fundamental value of a company and the share price will take care

Quintessence

Quintessence 2 minutes ago

SKK down 80%. Can if find a bottom and rebound? I have no idea why it is down so much today...It went up to $11 this morning and currents is at .86 - crazy! .

Giangy

Giangy 2 minutes ago

https://x.com/7219Giangy/status/1859677903606382791?t=SWHVO3XIDxD_3ZeMliI2Ww&s=19

exwannabe

exwannabe 2 minutes ago

There are five big pharma companies that can conduct cancer trials (together with NWBO) AND own complementary immunotherapy agents: Merck, BMY, AstraZeneca, Regeneron Pharmaceuticals, and Roche. If this is the deal and nothing more needs to be revealed from it, then why does NWBO not disclose the na

ducci1

ducci1 3 minutes ago

My pleasure!---Keeps Me Sharp--I'm Hopin!

nowwhat2

nowwhat2 3 minutes ago

Go Calvin Go !

https://investorshub.advfn.com/uimage/uploads/2024/11/21/ilmjmXRP_111111_21_HYPER_CALVIIN_xrP.jpg

Lone Clone

Lone Clone 3 minutes ago

Pacific Bay Completes Sphinx Mountain Rare Earth Field Program, Assays Pending

https://www.newsfilecorp.com/release/230804/Pacific-Bay-Completes-Sphinx-Mountain-Rare-Earth-Field-Program-Assays-Pending

November 21, 2024 8:00 AM EST | Source: Pacific Bay Minerals Ltd.

tmcfo

tmcfo 3 minutes ago

Near chicago, in northwest. indiana. And you?

Newc

Newc 3 minutes ago

$CAPC tiny floater with accumulation chart and rsi.

tmcfo

tmcfo 3 minutes ago

Near chicago, in northwest. indiana. And you?

Amigo Mike

Amigo Mike 3 minutes ago

Welp,

ZIVO stock is still holding up fairly strong against continued selling. The stock is still trying to absorb a seller who started out showing more than 7500 shares ..... it is now down to just under 2700 shares at $21.00 offered. Unfortunately other sellers have stepped in fron

trusttheman

trusttheman 3 minutes ago

As usual, Wave is lying and is a total fraud. Whatever they had to do in China has absolutely nothing to do with any of the deficiencies. For starters because your a troll and you don't talk to anybody in the company you don't understand anything. Deficiencies can be questions or comments. Nothing

glenn1919

glenn1919 3 minutes ago

INBS....................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

biotech-1953

biotech-1953 3 minutes ago

In EASL Congress of June 2024, both MDGL and LLY presented their results in fibrosis stages F2-F3 (you mention LLY presentation in your post). However, neither company addressed stage F4.

Then the price of MDGL immediately skyrocketed. According to quite a few analysts, MDGL (also

FooBarAndGrill

FooBarAndGrill 3 minutes ago

No news. The pump is due to Big Call options buys.

Retinalgenix Technologies (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions